11 development-"https:"-"https:"-"https:"-"https:"-"https:"-"https:" research jobs at Empa
Sort by
Refine Your Search
-
. Empa is a research institution of the ETH Domain. The Coating Technologies Group in Empa's Laboratory for Surface Science & Coating Technologies develops next-generation functional thin films through
-
worth living. Empa is a research institution of the ETH Domain. The Coating Technologies Group in Empa's Laboratory for Surface Science & Coating Technologies develops next-generation functional thin
-
. Empa is a research institution of the ETH Domain. Our passion lies in materials science and technology, and at the Urban Energy Systems Laboratory (UESL), we develop strategies and methods to support the
-
. The research project focuses on the development of solid electrode composites, so-called boosters, for next-generation redox-targeted flow batteries. In these systems, soluble redox mediators dissolved in
-
, reviewed and further developed. What the Fellowship Offers A 4-year fellowship, comparable in scope and ambition to an SNF/ERC Starting Grant. Funding for the fellow’s own salary, plus one doctoral (PhD
-
materials synthesis with synchrotron radiation, neutron scattering, spectroscopy and electroanalytical methods. A major research direction is the development of physical methods and models for the description
-
. Empa is a research institution of the ETH Domain. The Laboratory of Advanced Materials Processing (LAMP) is a multidisciplinary research unit that develops innovative functional modification of materials
-
. Empa is a research institution of the ETH Domain. Empa’s Centre for X-ray Analytics develops X-ray analytical and imaging methods for understanding materials structure in material, life- and medical
-
. Empa is a research institution of the ETH Domain. The Laboratory for Building Energy Materials and Components develops advanced and/or low eco-impact, porous materials for insulation, sorption, and
-
development of new sensors, support nanoparticle-based cellular reprogramming strategies and identify new omics-based biomarkers. We work closely with clinical partners and we focus on deep understanding